Related Experiment Video
Updated: Jul 31, 2026

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
GB virus C/hepatitis G virus infection in Indian blood donors and high-risk groups
Mayura M Desai1, Ramprasad B Pal, Dushyant D Banker
1Department of Microbiology, Sir Hurkisondas Nurrotumdas Medical Research Society, Sir Hurkisondas Nurrotumdas Hospital and Research Centre, Raja Rammohan Roy Road, Mumbai 400004, India. desaimayura@hotmail.com
Insights
Hepatitis G virus (HGV), also known as GB virus C (GBV-C), showed a low prevalence of 2.24% in at-risk Indian populations. Infections were primarily found in multi-transfused patients and were generally asymptomatic and self-limiting.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- Hepatitis G virus (HGV), or GB virus C (GBV-C), identified in 1995, is a potential cause of non-A-E post-transfusion hepatitis.
- Understanding HGV/GBV-C prevalence is crucial for managing parenteral transmission risks.
Purpose of the Study:
- To determine the prevalence of Hepatitis G virus (HGV)/GB virus C (GBV-C) RNA in at-risk populations and healthy controls in India.
- To investigate co-infections with other parenterally transmitted hepatitis viruses and assess clinical markers in HGV/GBV-C carriers.
Main Methods:
- Screening of 402 subjects (including multi-transfused patients, hemodialysis patients, and healthy controls) for HBsAg, HCV RNA, and HGV/GBV-C RNA.
- Analysis of co-infection rates and liver enzyme levels (ALT, alkaline phosphatase) in HGV/GBV-C positive individuals.
Main Results:
- HGV/GBV-C RNA prevalence was 2.24% among the tested subjects.
- All HGV/GBV-C positive cases were identified in multi-transfused thalassaemic subjects or hemodialysis patients; none were found in healthy controls.
- HGV/GBV-C infections were often asymptomatic, transient, and self-limiting, with some cases showing elevated liver enzymes or co-infection with other hepatitis viruses.
Conclusions:
- Hepatitis G virus (HGV)/GB virus C (GBV-C) exhibits a low prevalence in the Indian population studied.
- The virus primarily affects individuals with high-risk parenteral exposure, such as those undergoing frequent transfusions or dialysis.
- HGV/GBV-C infections appear to be generally asymptomatic and self-limiting, suggesting a low pathogenic potential.
Abstract:
The hepatitis G virus (HGV) or GB virus C (GBV-C) was discovered in 1995 as a putative agent of post-transfusion, non-A-E hepatitis. The present study was carried out with the aim to find the prevalence of this virus among various subject groups at risk for parenteral transmission as well as in healthy control subjects both individually and along with other parenterally transmitted hepatitis viruses. Of the 402 subjects tested, 6.22% were positive for the HBsAg surface antigen, 7.21% were positive for HCV RNA while only 2.24% were seen to be carriers of the HGV/GBV-C RNA. All the HGV/GBV-C positive cases were either multi-transfused thalassaemic subjects or hemodialysis patients. None of the healthy control subjects showed presence of the virus. Seven of the HGV/GBV-C positive subjects showed co-infection with one or more additional virological markers. Also, of the 9 HGV/GBV-C positive subjects, 5 showed elevated ALT levels while 4 showed elevated alkaline phosphatase levels. Overall our findings seem to indicate that HGV infections generally are asymptomatic, transient and self-limiting and the virus does not seem to show a very high prevalence among the Indian population.
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Rh Blood Group
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Cytomegalovirus Disease
Hepatitis
Viral Hepatitis I: Introduction

